PROLOR BIOTECH, INC. (PBTH) financial statements (2021 and earlier)

Company profile

Business Address 3 SAPIR STREET
NES-ZIONA, 74140
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments24
Cash and cash equivalents24
Restricted cash and investments0
Deposits current assets10
Prepaid expense and other current assets0
Total current assets:34
Noncurrent Assets
Property, plant and equipment1
Deposits noncurrent assets0
Other undisclosed noncurrent assets0
Total noncurrent assets:1
TOTAL ASSETS:36
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1
Accrued liabilities1
Employee-related liabilities0
Due to related parties0
Other undisclosed current liabilities1
Total current liabilities:2
Noncurrent Liabilities
Total liabilities:2
Stockholders' equity
Stockholders' equity attributable to parent, including:33
Common stock0
Additional paid in capital101
Other undisclosed stockholders' equity attributable to parent(68)
Total stockholders' equity:33
Other undisclosed liabilities and equity0
TOTAL LIABILITIES AND EQUITY:36

Income statement (P&L) ($ in millions)

12/31/2012
Operating expenses(18)
Other undisclosed operating income0
Operating loss:(18)
Nonoperating income0
Investment income, nonoperating0
Foreign currency transaction gain, before tax0
Interest and debt expense(0)
Net loss:(18)
Other undisclosed net income attributable to parent0
Net loss available to common stockholders, diluted:(18)

Comprehensive Income ($ in millions)

12/31/2012
Net loss:(18)
Comprehensive loss, net of tax, attributable to parent:(18)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: